Search Reset
Query > English > 2022
A Guide to the Main WIPO Services
This brochure outlines the range of global intellectual property (IP) services that are offered by WIPO to support businesses and individuals through the IP lifecycle. These services can help innovators and creators protect their inventions, trademarks and designs in multiple countries, and resolve their IP disputes, through free global databases of IP information, highly efficient and cost-effective global IP protection services, and neutral non-profit dispute resolution services.
Publication year: 2022
Collective Management of Copyright and Related Rights
Third edition
This third edition of Collective Management of Copyright and Related Rights presents an in-depth revision with invaluable updates on the different systems, legislative options and best practices of CMOs worldwide. As with previous editions, the book is written to reach a wide audience, with a special focus on questions that might emerge for governments as they prepare, adopt and apply collective management norms and regulations. The edition also sheds light on new copyright and related rights developments, including digital, technological and business trends, from all over the world. Additionally, there is detailed discussion on topics such as aspects of competition, national treatment, and different models of collective management.
WIPO Magazine, Issue 4/2022 (December)
The WIPO Magazine explores intellectual property, creativity and innovation in action across the world.
Patent Cooperation Treaty (PCT)
Regulations under the PCT (as in force from July 1, 2022)
The Patent Cooperation Treaty makes it possible to seek patent protection for an invention simultaneously in each of a large number of countries by filing an "international" patent application. Such an application may be filed by anyone who is a national or a resident of a Contracting State.
Patent Cooperation Treaty Yearly Review – 2022
The International Patent System
Comprehensive facts, figures and analysis of the international patent system. Special theme: How the COVID-19 crisis affected PCT application filings
Hague Yearly Review 2022 - Executive Summary
International Registration of Industrial Designs
This executive brief identifies key trends in the use of the WIPO-administered Hague System for the International Registration of Industrial Designs.
Guide to the International Patent Classification (2022)
This Guide provides information on the objectives, history and reform of the International Patent Classification (IPC) as well as assistance in the use of the IPC.
Guide to WIPO's services for country code top-level domain registries
This guide presents country code top-level domain (ccTLD) registry operators and national authorities with information on how to resolve third-party domain name disputes in a cost- and time-saving manner. It explains the main policy design features of a successful Alternative Dispute Resolution (ADR) system, and provides information on the WIPO-created Uniform Domain Name Dispute Resolution Policy (UDRP), including the possibility to tailor the UDRP for specific ccTLD requirements.
An integrated health, trade and IP approach to respond to the COVID-19 pandemic (Second update, May 2023)
The coronavirus disease 2019 (COVID-19) pandemic constitutes an extraordinary global public health crisis that has created a pressing need for intensified global cooperation. This updated information note maps the myriad challenges posed by the outbreak in relation to the integrated health, trade and IP policy frameworks. It provides cross-references to the relevant sections in the updated trilateral study
COVID-19-related vaccines and therapeutics
Preliminary insights on related patenting activity during the pandemic
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus and the related disease. This patent landscape report provides early observations on the patenting activity which took place in the field of COVID-19 vaccines and therapeutics, and compares results with clinical trial data for related candidate vaccines and drugs.